Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-24 @ 10:36 PM
NCT ID:
NCT02796235
Eligibility Criteria:
Inclusion Criteria:
* Age greater than 18 years.
* Patients having paraplegia or tetraplegia from C2 levels and above S1
* Paraplegia and tetraplegia of traumatic or non progressive SCI from traumatic or medical origin (ischemic, post-surgical, myelitis, benign tumor)
* Informed consent signed.
* stabilized respiratory situation with absence of chronic hypoxemia (hypoxemia being characterized by PaO2 steady state \<7.33 kPa)
* Patient not amputated.
* Absence of heart failure with ejection fraction below 30%
* Lack of solid neoplasia or progressive lymphoid haemopathy for 5 years, or myeloproliferative disorders (including polycythemia and thrombocythemia).
* No personal history of VTE and / or thrombophilia before the injury.
Exclusion Criteria:
* Unstabilized respiratory situation with presence of chronic hypoxemia (hypoxemia being characterized by PaO2 steady state \<7.33 kPa)
* Amputated Patient.
* Patients with heart failure with ejection fraction below 30%
* Solid neoplasia or progressive lymphoid haemopathy for 5 years, or myeloproliferative disorders (including polycythemia and thrombocythemia).
* Personal history of VTE and / or thrombophilia before the injury.
* Can not to follow during the study period
* Pregnant women
* Patient Refusal
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02796235
Study Brief:
Protocol Section:
NCT02796235